Licensing CDMO Santa Farma has a long-standing track record of producing drugs for leading multinational companies in Turkey under licensing agreements, signaling strong contract development and manufacturing organization (CDMO) capabilities. This presents sales opportunities for new CDMO partnerships, co-development arrangements, and licensing collaborations with pharmaceutical players seeking reliable, scalable production partners.

HR Excellence The company highlights people-centric recognition, including multiple Respect for People awards, and has launched Santa Farma Academy to improve employee performance. This suggests a potential fit for HR services, training platforms, and learning solutions aimed at workforce development, leadership programs, or supplier and partner training initiatives.

Growth Potential With a large-scale revenue footprint and a stated aim to outpace market growth, Santa Farma offers opportunities for enterprise software, automation, and supply chain enhancements. Proposals could include ERP optimization around SAP FICO, manufacturing analytics, quality and compliance systems, and scalable partnering programs to support rapid growth.

Academic Partnerships Their Koç University Rams collaboration and the launch of Santa Farma Academy highlight openness to research partnerships and education initiatives. Potential sales angles include research collaborations, continuing medical education programs, e-learning platforms, and joint development projects with academic institutions.

Tech Modernization Santa Farma maintains a modern tech footprint including SAP FICO, Adobe suites, C#, and mapping tools, indicating readiness for digital transformation and integration. Opportunities exist for cybersecurity hardening, cloud migration, data analytics, system integrations, and digital marketing or training solutions that align with GMP and regulatory requirements.